March 2023 in “Медицинский совет” This review discusses various types of hair loss associated with COVID-19 and vaccinations, highlighting acute telogen hair loss as the most common form, but reports no new clinical results.
January 2023 in “International Journal of Dermatology and Venereology” This study found that a high percentage of patients reported experiencing hair loss following a COVID-19 infection, with more severe cases linked to more significant hair loss.
January 2023 in “Sibirskij medicinskij vestnik” This analysis explores possible causes of menstrual irregularities in women with PCOS following COVID-19, but reports no new clinical findings.
December 2022 in “Journal of Education, Health and Sport” This review suggests that combining treatments such as oral supplements, topical minoxidil, and high-platelet plasma may be effective for addressing telogen effluvium after COVID-19 infection, which affects about 30% of patients.
November 2022 in “Revista Hospital Clínico Universidad de Chile” This review discusses the potential relationship between Telogen effluvium and COVID-19 and reports no new clinical findings, highlighting the impact on patients' lives and the need for further investigation.
November 2022 in “Journal of clinical images and medical case reports” The researchers reported that COVID-induced telogen effluvium can occur after both severe and mild infections, potentially presenting earlier than other causes, and necessitates specific patient management due to its psychological impact.
June 2022 in “Research, Society and Development” This literature review explores post-COVID-19 telogen effluvium, noting multiple potential causes for hair loss and highlighting the absence of a specific treatment, based on existing dermatology guidelines.
April 2022 in “Brazilian Medical Students” This review synthesizes existing evidence on the link between androgenic alopecia and severe COVID-19 outcomes, noting a potential role for anti-androgenic therapies in treating SARS-CoV-2 infections.
March 2022 in “Journal of Clinical Case Studies Reviews & Reports” COVID-19 can cause or worsen skin conditions and might show early signs of infection.
March 2022 in “Journal of clinical case studies reviews & reports” COVID-19 can cause different skin issues, including rashes and hair loss.
February 2022 in “Journal of clinical research and reports” This article discusses the potential uses of plasma therapy for various conditions, including wound healing and Covid-19, but presents no new clinical findings; the authors highlight its increased demand since the Covid-19 outbreak.
January 2022 in “Journal Of Biotechnology And Crop Science” This review explores the pharmacological effects of Glycyrrhiza glabra, or liquorice, highlighting its antioxidant, anti-inflammatory, antimicrobial, and antiviral properties, but reports no new experimental results.
January 2022 in “Annals of Institute of Biology University of Sarajevo” This study reviewed previous research and highlights the potential of plant-derived compounds as anti-coronaviral agents, emphasizing the inhibition of viral enzymes and the need for further natural-origin antiviral investigations.
December 2021 in “The Sri Lanka Journal of Dermatology” This study found that the prevalence of dermatological manifestations in COVID-19 patients was 1.7% in Sri Lanka, with various types of skin lesions reported.
October 2021 in “Brazilian Journal of Health Review” This review discusses common dermatological findings related to SARS-CoV-2 infection, noting their variability and potential psychological impact, but reports no new clinical results; further studies are needed for precise characterization.
February 2021 in “International Journal of Research in Dermatology” This review explores dermatological manifestations and cutaneous drug reactions associated with COVID-19, providing insights for clinicians on recognizing these signs and understanding their potential mechanisms, but it reports no new clinical results.
November 2020 in “Holistic Nursing Practice” This article discusses varied presentations of COVID-19, emphasizing that healthcare professionals should consider less typical symptoms, such as telogen effluvium, anosmia, and COVID toes, in patient assessments.
October 2020 in “Проблемы эндокринологии” This review discusses the potential roles of androgens and antiandrogens in COVID-19 outcomes, noting unresolved questions about their effectiveness and safety for treatment.
September 2020 in “Annals of the National Academy of Medical Sciences. India” This article discusses the impact of COVID-19 on skin health, highlighting various cutaneous manifestations and the need for dermatologists to adapt their practices during the pandemic, but it reports no new results.
June 2020 in “Journal of Dermatological Treatment” This source outlines the potential effects of treatments commonly used in trichology on SARS-CoV-2 infection and offers a guide for managing trichological patients during the COVID-19 era, addressing the challenges of safely visiting and treating patients.
January 2020 in “DOAJ (DOAJ: Directory of Open Access Journals)” This survey among members of the Association of Hair Restoration Surgeons of India explored the impact of COVID-19 on hair transplant surgery, highlighting challenges posed by halted operations and financial implications.
December 2011 in “Asia-Pacific biotech news” This collection of research news highlights various scientific advancements, including discoveries in anti-cancer compounds, new cell types that boost immunity, and a potential Parkinson's breakthrough in Australia, among others from China, India, Korea, Singapore, and Thailand.
Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.
December 2008 in “Enzyme and Microbial Technology” New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.
July 2003 in “Journal of Cutaneous Medicine and Surgery” Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.
July 2003 in “Journal of Cutaneous Medicine and Surgery” Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.
July 2003 in “Journal of Cutaneous Medicine and Surgery” Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.
July 2003 in “Journal of Cutaneous Medicine and Surgery” The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.
July 2003 in “Journal of Cutaneous Medicine and Surgery” High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.
July 2003 in “Journal of Cutaneous Medicine and Surgery” Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.